Soros Fund Management - SALIX PHARMACEUTICALS INC ownership

SALIX PHARMACEUTICALS INC's ticker is SLXP and the CUSIP is 795435106. A total of 1 filers reported holding SALIX PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Soros Fund Management ownership history of SALIX PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2015$34,891,000
-38.2%
201,903
-58.9%
0.34%
-44.4%
Q4 2014$56,497,000491,5310.62%
Other shareholders
SALIX PHARMACEUTICALS INC shareholders Q2 2015
NameSharesValueWeighting ↓
Zurcher Kantonalbank (Zurich Cantonalbank) 173,845$7,037,0000.28%
AMUNDI ASSET MANAGEMENT US, INC. 537,900$21,774,0000.09%
NOMURA HOLDINGS INC 127,903$5,175,0000.06%
GOLDMAN SACHS GROUP INC 386,458$15,641,0000.01%
AQR Capital Management 26,000$1,052,0000.01%
GOLDMAN SACHS GROUP INC 100,000$4,047,0000.00%
RATIONAL ADVISORS LLC 288$12,0000.00%
HSBC HOLDINGS PLC 5,448$220,0000.00%
View complete list of SALIX PHARMACEUTICALS INC shareholders